University of Cambridge > > Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer > Tumour suppressor and tumour maintenance genes

Tumour suppressor and tumour maintenance genes

Add to your list(s) Download to your calendar using vCal

  • UserScott Lowe, Memorial Sloan Kettering Cancer Centre, New York
  • ClockTuesday 22 March 2016, 13:00-14:00
  • HouseCRUK CI Lecture Theatre.

If you have a question about this talk, please contact Kate Davenport.

Please note this seminar is on a Tuesday

Cancer arises through an evolutionary process whereby normal cells acquire mutations that erode growth controls, leading to the expansion of aberrantly proliferating cells. Such mutations activate oncogenes or inactivate tumor suppressors, each bestowing new capabilities to emerging tumors. Still, cancer is not an inevitable consequence of mutation but is instead kept in check by intrinsic tumor-suppressor programs activated in damaged cells. Accordingly, our laboratory studies such mechanism in order to reveal key regulatory nodes controlling basic cellular processes and to identify the strategies nature uses to combat cancer. More recently, our interests have expanded to explore the action of tumor maintenance genes – those genes needed to sustain the proliferation and survival of malignant cancer cells – with the goal of dentifying cancer vulnerabilities and therapeutic targets. Our approach combines powerful mouse models, genetics, and genomics in a coordinated manner that allows us to study tumor suppressor and tumor maintenance networks in a comprehensive way. Recent efforts to characterize tumor suppressor gene action and the consequences of tumor suppressor gene loss will be discussed.

This talk is part of the Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2022, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity